Bringing the fundamentals into focus…
Back to Immunome, Inc.
How Immunome, Inc. stacks up
IMNM · against 347 other Healthcare companies of similar size
Growth
8/ 100
Near the bottom of its peers.
Ranked #325 of 348 · scores higher than 5% of peers
Bars: peers in each 10-point band of the growth score26 peers with a growth score of 0–9, including IMNM · Click a bar to see the companies
Why growth scores 8?
Weighted metrics compared with all Healthcare companies.Mainly because of its revenue growth, which is weaker than most Healthcare peers.
- slower revenue growth over the last year: weaker than 100% of peers. Revenue growth: -100.0% vs peer median 6.1%
- 3-year revenue growth is not reported, so it is left out of the score.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
Metric by metric
Position: dot = IMNM, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | IMNM | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 348 reported | -100.0% | 7.0% | 0% | 33% | |
| Earnings per share growthHigher is better · 202 reported | Not reported | 9.8% | — | — | 33% |
| 3-year revenue growthHigher is better · 339 reported | Not reported | 8.1% | — | — | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around IMNM| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 2 | 1.4B USD | 99 | 73 | |
| 2 | 27.6B SEK (≈$2.8B) | 99 | 76 | |
| 2 | 2.1B USD | 99 | 96 | |
| 2 | 2.8B USD | 99 | 51 | |
| 322 | 15.0B CNY (≈$2.1B) | 10 | 55 | |
| 323 | 26.5B CNY (≈$3.7B) | 9 | 69 | |
| 323 | 3.7B USD | 9 | 24 | |
| 325 | 3.7B USD | 8 | 31 | |
| 325 | 2.4B USD | 8 | 27 | |
| 325 | 1.3B USD | 8 | 20 | |
| 325 | 2.4B USD | 8 | 20 | |
| 325 | 3.4B USD | 8 | 55 | |
| 330 | 9.3B CNY (≈$1.3B) | 7 | 32 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score